DBTX insider filings
Decibel Therapeutics, Inc. — 14 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-09-25. Screen DBTX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for DBTX between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Decibel Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-09-25 | 4 | Trask Anna — Chief People Officer | Disposition to issuer (D): 106,864 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 52,500 (derivative) · Disposition to issuer (D): 137,302 (derivative) | EDGAR |
| 2023-09-25 | 4 | Carson William H. — Director | Disposition to issuer (D): 5,000 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) | EDGAR |
| 2023-09-25 | 4 | Lee John Jui-Jen — Chief Development Officer | Disposition to issuer (D): 147,144 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 52,500 (derivative) · Disposition to issuer (D): 232,003 (derivative) | EDGAR |
| 2023-09-25 | 4 | FINGER ALISON CECILY — Director | Disposition to issuer (D): 5,000 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) | EDGAR |
| 2023-09-25 | 4 | Nochur Sara — Director | Disposition to issuer (D): 5,000 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) | EDGAR |
| 2023-09-25 | 4 | Kapusta Matthew C — Director | Disposition to issuer (D): 10,000 · Disposition to issuer (D): 10,000 (derivative) | EDGAR |
| 2023-09-25 | 4 | Reid Laurence — See Remarks, Director | Disposition to issuer (D): 220,849 · Disposition to issuer (D): 187,500 (derivative) · Disposition to issuer (D): 72,000 (derivative) · Disposition to issuer (D): 1,072,539 (derivative) | EDGAR |
| 2023-09-25 | 4 | MCLAUGHLIN KEVIN F — Director | Disposition to issuer (D): 5,000 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) | EDGAR |
| 2023-06-14 | 4 | Nochur Sara — Director | Grant/award (A): 5,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2023-06-14 | 4 | Carson William H. — Director | Grant/award (A): 5,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2023-06-14 | 4 | FINGER ALISON CECILY — Director | Grant/award (A): 5,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2023-06-14 | 4 | MCLAUGHLIN KEVIN F — Director | Grant/award (A): 5,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2023-03-21 | 4 | Kapusta Matthew C — Director | Grant/award (A): 10,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-03-17 | 4 | Reid Laurence — See Remarks, Director | Grant/award (A): 195,000 @ $0 · Grant/award (A): 72,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Decibel Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-09-25 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-08-25 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-08-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-04-06 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-03-13 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=DBTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →